SCHEMBL8339096

SCHEMBL8339096

Bc1ccc(S(=O)(=O)N(CC(=O)N(CC)CC)c2ccc(C)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HCRTR2 O43614 11/20 0.77
▸ ALDH1A1 P00352 3/20 0.74
▸ KEAP1 Q14145 1/20 0.60
▸ NFE2L2 Q16236 1/20 0.60
▸ TSHR P16473 1/20 0.51
▸ PPARG P37231 1/20 0.50
▸ CNR1 P21554 1/20 0.49
▸ CNR2 P34972 1/20 0.49
▸ MAPT P10636 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ HCRTR1 O43613 1/20 0.47
▸ ESR1 P03372 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1040488 0.87 HCRTR2 (1.00) HCRTR2ALDH1A1KEAP1NFE2L2TSHR
SCHEMBL1039054 0.87 HCRTR2 (0.77) HCRTR2ALDH1A1KEAP1NFE2L2TSHR
SCHEMBL1039401 0.85 HCRTR2 (0.74) HCRTR2ALDH1A1KEAP1NFE2L2TSHR
SCHEMBL1039013 0.85 HCRTR2 (1.00) HCRTR2ALDH1A1KEAP1NFE2L2TSHR
SCHEMBL1039891 0.81 HCRTR2 (0.73) HCRTR2ALDH1A1KEAP1NFE2L2MAPT
SCHEMBL1041090 0.81 HCRTR2 (1.00) HCRTR2ALDH1A1KEAP1NFE2L2CNR1
SCHEMBL1040064 0.81 HCRTR2 (0.73) HCRTR2ALDH1A1KEAP1NFE2L2NPSR1
SCHEMBL1037275 0.81 HCRTR2 (0.72) HCRTR2ALDH1A1KEAP1NFE2L2MAPT
SCHEMBL8340688 0.79 HCRTR2 (0.64) HCRTR2ALDH1A1KEAP1NFE2L2HCRTR1
SCHEMBL1040574 0.79 HCRTR2 (0.65) HCRTR2ALDH1A1KEAP1NFE2L2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554239-B1 SULFONYLAMINO-ACETIC ACID DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2011-01-26 — — EP disclosed
WO-2004033418-A2 SULFONYLAMINO-ACETIC DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD. (CH) 2004-04-22 — — WO disclosed
Send feedback